International audienceAn important bottleneck for non-viral gene transfer commonly relates to translocation of nucleic acids into the nuclear compartment of target cells. So-called 3NFs are optimized short nucleotide sequences able to interact with the transcription factor nuclear factor κB (NF-κB), which can enhance the nuclear import of plasmid DNA (pDNA) carrying such motifs. In this work, we first designed a consistent set of six pDNAs featuring a common backbone and only varying in their 3NF sequences. These constructions were then transfected under various experimental settings. In vitro, cationic polymer-assisted pDNA delivery in five human-derived cell lines showed the potential advantage of 3NF carrying pDNA in diverse cellular con...
An interest in nuclear proteins as possible gene vectors arose as early as 1988. Nuclear proteins po...
The aim of gene therapy is to treat, cure or prevent a disease by replacing defective genes, introdu...
The ability of nonviral gene delivery systems to overcome extracellular and intracellular barriers i...
International audienceAn important bottleneck for non-viral gene transfer commonly relates to transl...
Gene therapy provides a great hope for the treatment of many acquired and inherited life-threatening...
International audienceBackground The nuclear factor kappa B (NFκB) transcription factor, which shutt...
International audienceQuantification of a plasmid DNA (pDNA) and investigation of its polymer-associ...
Import of exogenous plasmid DNA (pDNA) into mammalian cell nuclei represents a key intracellular obs...
Background Non-viral gene delivery vectors are multi-component systems reflecting various functiona...
Several barriers have to be overcome in order to achieve gene expression in target cells, e.g. cellu...
To improve the nuclear-targeted delivery of non-viral vectors, extensive effort has been carried out...
Several barriers have to be overcome in order to achieve gene expression in target cells, e.g. cellu...
Gene therapy utilizes genetic material in order to cure patients either by DNA vaccines or by replac...
An interest in nuclear proteins as possible gene vectors arose as early as 1988. Nuclear proteins po...
The aim of gene therapy is to treat, cure or prevent a disease by replacing defective genes, introdu...
The ability of nonviral gene delivery systems to overcome extracellular and intracellular barriers i...
International audienceAn important bottleneck for non-viral gene transfer commonly relates to transl...
Gene therapy provides a great hope for the treatment of many acquired and inherited life-threatening...
International audienceBackground The nuclear factor kappa B (NFκB) transcription factor, which shutt...
International audienceQuantification of a plasmid DNA (pDNA) and investigation of its polymer-associ...
Import of exogenous plasmid DNA (pDNA) into mammalian cell nuclei represents a key intracellular obs...
Background Non-viral gene delivery vectors are multi-component systems reflecting various functiona...
Several barriers have to be overcome in order to achieve gene expression in target cells, e.g. cellu...
To improve the nuclear-targeted delivery of non-viral vectors, extensive effort has been carried out...
Several barriers have to be overcome in order to achieve gene expression in target cells, e.g. cellu...
Gene therapy utilizes genetic material in order to cure patients either by DNA vaccines or by replac...
An interest in nuclear proteins as possible gene vectors arose as early as 1988. Nuclear proteins po...
The aim of gene therapy is to treat, cure or prevent a disease by replacing defective genes, introdu...
The ability of nonviral gene delivery systems to overcome extracellular and intracellular barriers i...